EE278 Model-Projected Long-Term Clinical Outcomes of Exagamglogene Autotemcel (exa-cel) Gene-Edited Therapy in Patients with Sickle Cell Disease with Recurrent Vaso-Occlusive Crises in the United Kingdom
Abstract
Authors
A. Lopez S. Jeyakumar Y. Xie H. Yang N. Li D. Fattah J. Howard J. Wang C. Udeze